Mar 04, 2021 Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
Jan 06, 2021 Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences
Nov 09, 2020 Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
Nov 04, 2020 Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
Sep 17, 2020 Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
Sep 10, 2020 Checkpoint Therapeutics to Participate in Three September 2020 Virtual Investor Conferences
Aug 17, 2020 Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
Aug 05, 2020 Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights